AzTrials
AzTrials

StrokeiCOSMONCT06498011

COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO)

A study testing Home Graded Repetitive Arm Supplementary Program (GRASP) and integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO) in people with Stroke and CVA, run by University Health Network, Toronto at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The iCOSMO study investigates the feasibility and beneficial effects of an intervention combining sensation, motor and cognition to improve arm and hand function after chronic stroke. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, CVA, Cerebrovascular Accident
What is being tested?
Home Graded Repetitive Arm Supplementary Program (GRASP) and integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteCanada
Study dates
1 Aug 2024to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of stroke
  • Must be more than 6 months post-stroke
  • Must be above 18 years old
  • Must have some motor and/or somatosensory deficits in the upper limbs

Who cannot join

  • A prior history of central nervous system dysfunction other than stroke
  • Upper limb deficits resulting from non-stroke pathology
  • Inability to cooperate, follow instructions or provide consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • Toronto Rehabilitation Institute

    Toronto, Ontario, M5G2A1

    Urvashy Gopaul, PhD, 416-597-3422 ext. 7996, urvashy.gopaul@uhn.ca

    Olga Yaroslavtseva, BSc, 416-597-3422, olga.yaroslavtseva@uhn.ca

    Recruiting

Other trials in Canada

About this study

Official title: Comparing the Effect of a Graded Repetitive Arm Supplementary Home-based Exercise Programme With COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO)

The iCOSMO study investigates the feasibility and beneficial effects of an intervention combining sensation, motor and cognition to improve arm and hand function after chronic stroke.

Read the detailed description

The iCOSMO is a two-arm randomized controlled trial study evaluating the feasibility and efficacy of combined somatosensory-motor intervention using a cognitive approach to improve upper limb recovery in people with chronic stroke. Forty participants will be recruited (20 in experimental group and 20 in the control group). iCOSMO will include active touch and movement exploratory procedures during goal-oriented tasks as well as robotic training using the Kinarm Exoskeleton device. The experimental group will receive a total of 36 hours of treatment (6 weeks). The control group will receive a matched dose of a home-based motor exercise programme. The outcome measures will include measures of feasibility such as the recruitment and adherence rates and standardised clinical and robotic assessments. The participants will be tested at the start and end of the baseline phase, at post-intervention and at 1-month follow-up.

Being tested
Home Graded Repetitive Arm Supplementary Program (GRASP), integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO)
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home Graded Repetitive Arm Supplementary Program (GRASP)Other

    The home-based exercise programme will be based on the Home Graded Repetitive Arm Supplementary Program focusing on stretching, arm strengthening, hand strengthening, coordination and hand skills. The Home Graded Repetitive Arm Supplementary Program will be delivered 2 hours/session, 3 times/week, for 6 weeks.

  • integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO)Other

    The first training approach of iCOSMO will focus on integrated somatosensory-motor variables during reaching and object manipulation (60 minutes). The second training approach will focus on proprioceptive, motor and cognitive tasks using the Kinarm robotic exoskeleton (60 minutes). iCOSMO will be delivered 3 times per week (2 hours per session) for 6 weeks (Total: 36 hours of treatment).

Study groups in NCT06498011
Study groupRoleWhat they receive
iCOSMOExperimental20 participants will receive the iCOSMO intervention. iCOSMO consists of two training approaches that will include active touch and movement exploratory procedures during goal-oriented tasks as well as robotic training using the Kinarm Exoskeleton device.
Receives: Other: integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO)
Home GRASPActive comparator20 participants will receive the control intervention. The control group will receive a matched dose of a home-based exercise programme. The home-based exercise programme will be based on the Home Graded Repetitive Arm Supplementary Program.
Receives: Other: Home Graded Repetitive Arm Supplementary Program (GRASP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fidelity

    Measures of fidelity will monitor intervention delivery such as the number of intervention sessions attended and the amount of practice.

    Measured: Through study completion, an average of 6 weeks

  2. Kinarm standard tasks- the Reverse Visually Guided Reaching

    The Kinarm standard tasks™ will include the Reverse Visually Guided Reaching. The Reverse Visually Guided Reaching task assesses attention, inhibitory control and cognitive control of visuomotor skills. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  3. Kinarm standard tasks- the Trail Making A&B

    The Kinarm standard tasks™ will include the Trail Making A\&B. The Trail Making tests evaluate task switching abilities. There are 2 parts of this test. Trail A: trace a sequence of targets numbered 1 to 25; Trail B: Trace alternating numeric-alpha sequence of targets 1-A-2-B etc. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  4. Kinarm standard tasks- the Object Hit and Avoid

    The Kinarm standard tasks™ will include the Object Hit and Avoid. The Object Hit and Avoid task assesses spatial attention, rapid motor selection and inhibition control. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  5. Kinarm standard tasks- the Spatial Span Task

    The Kinarm standard tasks™ will include the Spatial Span Task. The Spatial Span test evaluates visuospatial working memory. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  6. Kinarm standard tasks- the Paired Associates Learning

    The Kinarm standard tasks™ will include the Paired Associates Learning. The Paired Associates Learning task evaluates visuospatial working memory by testing the ability to associate patterns with spatial locations and recall them after a delay. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  7. Kinarm standard tasks- the Visually Guided Reaching

    The Kinarm standard tasks™ will include the Visually Guided Reaching. The Visually Guided Reaching task measures the subject's visuomotor capabilities and multi-joint coordination. A task score will reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  8. Kinarm standard tasks- the Object Hit

    The Kinarm standard tasks™ will include the Object Hit. The Object Hit task is a rapid sensorimotor decision and control test. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  9. Kinarm standard tasks- the Ball-on-Bar

    The Kinarm standard tasks™ will include the Ball-on-Bar. The Ball on Bar task assesses bimanual coordination and visuomotor skills. A task score will reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  10. Kinarm standard tasks- the Arm Posture Perturbation

    The Kinarm standard tasks™ will include the Arm Posture Perturbation. The Arm Posture Perturbation task assesses the responsiveness to unexpected disturbances to the arm. A task score will reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  11. Kinarm standard tasks- the Arm Positioning Matching

    The Kinarm standard tasks™ will include the Arm Positioning Matching: The Arm Position Matching task measures of a subject's proprioceptive capabilities in the upper limb. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  12. Kinarm standard tasks- the Arm Movement Matching

    The Kinarm standard tasks™ will include the Arm Movement Matching: The Arm Movement Matching task assesses the ability of a subject to perceive limb motion or kinesthesia in a workspace. A task score will be reported as a measure of a participant's performance against healthy populations.

    Measured: Baseline, immediately after intervention,1-month

  13. Fugl-Meyer Assessment-Upper Extremity (FMA-UE)

    FMA-UE provides quantitative measures of sensory and motor impairments in the upper limbs and is scored from 0-66.

    Measured: Baseline, immediately after intervention,1-month

  14. Action Research Arm Test (ARAT)

    The ARAT assesses motor performance of the upper limb. It consists of 19 tasks across the 4 subscales (grasp, grip, pinch, gross movement).

    Measured: Baseline, immediately after intervention,1-month

  15. Grip dynamometry

    Maximum voluntary grip strength with the Jamar dynamometer will be used as a conventional measure of muscle strength in the upper limb post-stroke.

    Measured: Baseline, immediately after intervention,1-month

  16. Pinch strength

    Pulp-to-pulp pinch strength will be assessed using a pinch gauge (B \& L Engineering).

    Measured: Baseline, immediately after intervention,1-month

  17. Box and Block Test (BBT)

    The BBT will be used to assess gross manual dexterity.

    Measured: Baseline, immediately after intervention,1-month

Secondary outcomes (2)
  1. Stanford Fatigue Visual Analogue Scale (SFVAS)

    The SFVAS, a single-item scale with a rating of 1 (no fatigue) to 10 (severe fatigue), will be used to assess the presence and extent of mental and physical fatigue.

    Measured: Through study completion, an average of 6 weeks

  2. Pain visual analogue scale (PVAS)

    PVAS is a single-item scale ranging from 0 (no pain) to 10 (excruciating pain).

    Measured: Through study completion, an average of 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2024
  2. Study start1 Aug 2024
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06498011
Sponsor's protocol ID
22-5628
Acronym
iCOSMO
Status last verified
Dec 2024
First submitted
24 Jun 2024
Last updated
11 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We do not plan to share the data from this study with any researchers outside this study.

Publications

  • Gopaul U, van Vliet P, Callister R, Nilsson M, Carey L. COMbined Physical and somatoSEnsory training after stroke: Development and description of a novel intervention to improve upper limb function. Physiother Res Int. 2019 Jan;24(1):e1748. doi: 10.1002/pri.1748. Epub 2018 Sep 19.

    PubMed 30230136
  • Birkenmeier RL, Prager EM, Lang CE. Translating animal doses of task-specific training to people with chronic stroke in 1-hour therapy sessions: a proof-of-concept study. Neurorehabil Neural Repair. 2010 Sep;24(7):620-35. doi: 10.1177/1545968310361957. Epub 2010 Apr 27.

    PubMed 20424192
  • Ritter PL, Gonzalez VM, Laurent DD, Lorig KR. Measurement of pain using the visual numeric scale. J Rheumatol. 2006 Mar;33(3):574-80.

    PubMed 16511926
  • Bourke TC, Lowrey CR, Dukelow SP, Bagg SD, Norman KE, Scott SH. A robot-based behavioural task to quantify impairments in rapid motor decisions and actions after stroke. J Neuroeng Rehabil. 2016 Oct 10;13(1):91. doi: 10.1186/s12984-016-0201-2.

    PubMed 27724945
  • Duncan PW, Propst M, Nelson SG. Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther. 1983 Oct;63(10):1606-10. doi: 10.1093/ptj/63.10.1606.

    PubMed 6622535
  • Ekstrand E, Lexell J, Brogardh C. Grip strength is a representative measure of muscle weakness in the upper extremity after stroke. Top Stroke Rehabil. 2016 Dec;23(6):400-405. doi: 10.1080/10749357.2016.1168591. Epub 2016 May 4.

    PubMed 27145212
  • Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the Box and Block Test of manual dexterity. Am J Occup Ther. 1985 Jun;39(6):386-91. doi: 10.5014/ajot.39.6.386.

    PubMed 3160243

Questions about this trial

What is this clinical trial studying?

A study testing Home Graded Repetitive Arm Supplementary Program (GRASP) and integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO) in people with Stroke and CVA, run by University Health Network, Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Urvashy Gopaul, PhD (416-597-3422 ext. 7996, urvashy.gopaul@uhn.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fidelity (time frame: Through study completion, an average of 6 weeks). The study lists 17 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06498011, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in